INCORPORATION OF INTRAPERITONEAL INSULIN DELIVERY IN THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR: MODEL PREDICTIVE CONTROL IN SILICO TRIALS VS THE SUBCUTANEOUS ROUTE

被引：0
|
作者：
Toffanin, C. [1 ]
Schiavon, M. [2 ]
Aiello, E. [1 ]
Cobelli, C. [2 ]
Magni, L. [1 ,3 ]
机构：
[1] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy
[2] Univ Padua, Dept Informat Engn, Padua, Italy
[3] Univ Pavia, Dept Civil & Architecture Engn, Pavia, Italy
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
411
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 48 条
  • [1] Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator
    Visentin, Roberto
    Schiavon, Michele
    Giegerich, Clemens
    Klabunde, Thomas
    Dalla Man, Chiara
    Cobelli, Claudio
    2018 40TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2018, : 4905 - 4908
  • [2] INCORPORATION OF THE SENSOR-AUGMENTED INSULIN-PUMP THERAPY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR
    Visentin, R.
    Vettoretti, M.
    Facchinetti, A.
    Dalla Man, C.
    Sparacino, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A130 - A130
  • [3] INCORPORATION OF INTRA-DAY VARIABILITY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR
    Visentin, R.
    Dalla Man, C.
    Kovatchev, B. P.
    Cobelli, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A52 - A53
  • [4] Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies
    Visentin, Roberto
    Schiavon, Michele
    Giegerich, Clemens
    Klabunde, Thomas
    Dalla Man, Chiara
    Cobelli, Claudio
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2019, 66 (10) : 2889 - 2896
  • [5] Incorporation of Inhaled Insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator
    Visentin, Roberto
    Klabunde, Thomas
    Grant, Marshall
    Dalla Man, Chiara
    Cobelli, Claudio
    2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2015, : 3250 - 3253
  • [6] In Silico Modeling of the Performance of a Novel Closed-Loop Algorithm Using the UVA/PADOVA Type 1 Diabetes Simulator
    Dedeshko, Alexey J.
    Fedotov, Vitaly
    Simic, Amra
    Thivolet, Charles
    Mader, Julia K.
    DIABETES, 2022, 71
  • [7] Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes
    S. Pasquini
    G. Da Prato
    G. Tonolo
    E. Bonora
    M. Trombetta
    Acta Diabetologica, 2020, 57 : 101 - 104
  • [8] Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes
    Pasquini, S.
    Da Prato, G.
    Tonolo, G.
    Bonora, E.
    Trombetta, M.
    ACTA DIABETOLOGICA, 2020, 57 (01) : 101 - 104
  • [9] Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study
    Dassau, Eyal
    Renard, Eric
    Place, Jerome
    Farret, Anne
    Pelletier, Marie-Jose
    Lee, Justin
    Huyett, Lauren M.
    Chakrabarty, Ankush
    Doyle, Francis J., III
    Zisser, Howard C.
    DIABETES OBESITY & METABOLISM, 2017, 19 (12): : 1698 - 1705
  • [10] Reshaping Model Predictive Control Penalties for an Automated Insulin Delivery System in Type 1 Diabetes
    Moscoso-Vasquez, Marcela
    Garcia-Tirado, Jose
    Colmegna, Patricio
    Breton, Marc
    IFAC PAPERSONLINE, 2023, 56 (02): : 9660 - 9665
12345